CUSIP: 45168K405
What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 45168K405:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q1 | 0 | $0 | -$1,129,615 | 0 | |
| 2022 Q4 | 3,232,193 | $1,129,615 | -$90,149 | $0.35 | 29 |
| 2022 Q3 | 3,476,812 | $1,299,776 | -$47,510 | $0.37 | 28 |
| 2022 Q2 | 3,592,787 | $1,647,000 | -$91,929 | $0.46 | 26 |
| 2022 Q1 | 3,721,326 | $1,858,000 | -$271,580 | $0.50 | 24 |
| 2021 Q4 | 4,247,605 | $2,420,000 | -$1,660,631 | $0.57 | 28 |
| 2021 Q3 | 6,205,711 | $6,389,000 | -$295,494 | $1.03 | 42 |
| 2021 Q2 | 6,333,432 | $7,596,000 | -$4,622,822 | $1.20 | 41 |
| 2021 Q1 | 9,829,694 | $12,772,143 | -$1,540,621 | $1.30 | 52 |
| 2020 Q4 | 9,537,334 | $35,003,022 | +$2,431,945 | $3.67 | 51 |
| 2020 Q3 | 8,826,088 | $18,886,013 | +$11,404 | $2.14 | 37 |
| 2020 Q2 | 8,839,528 | $15,822,195 | +$351,796 | $1.79 | 39 |
| 2020 Q1 | 8,662,129 | $11,432,144 | -$691,663 | $1.32 | 39 |
| 2019 Q4 | 9,019,560 | $16,416,198 | -$971,484 | $1.82 | 43 |
| 2019 Q3 | 9,425,171 | $27,240,982 | -$2,624,467 | $2.89 | 46 |
| 2019 Q2 | 10,407,305 | $27,787,451 | -$4,516,078 | $2.67 | 52 |
| 2019 Q1 | 12,266,397 | $31,278,850 | -$328,469 | $2.55 | 66 |
| 2018 Q4 | 12,288,514 | $34,038,593 | +$2,565,312 | $2.77 | 81 |
| 2018 Q3 | 11,305,184 | $100,689,455 | -$260,428,748 | $8.91 | 67 |
| 2018 Q2 | 40,529,885 | $53,499,000 | +$53,499,000 | $1.32 | 4 |